Hu et al.'s [9] study collected the clinicopathological characteristics of 400 female patients clinically diagnosed with double primary lung cancer and breast cancer and determined that hormone receptor expression correlates with EGFR gene mutation. The gene discussed is EGFR; the disease is breast carcinoma.